These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 300259)
1. The 'wet dog shake" behaviour in the rat and 5-hydroxytryptamine [proceedings]. Bedard P; Pycock C Br J Pharmacol; 1977 Mar; 59(3):450P-451P. PubMed ID: 300259 [No Abstract] [Full Text] [Related]
2. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat. Yap CY; Taylor DA Neuropharmacology; 1983 Jul; 22(7):801-4. PubMed ID: 6604883 [TBL] [Abstract][Full Text] [Related]
3. Metoclopramide antagonism of 5-hydroxytryptophan-induced 'wet-dog' shake behaviour in the rat [proceedings]. Fozard JR; Palfreyman MG Br J Pharmacol; 1978 Jun; 63(2):387P-388P. PubMed ID: 307422 [No Abstract] [Full Text] [Related]
4. Serotoninergic manipulation of the behavioral effects of cocaine in rats. Pradhan SN; Battacharyya AK; Pradhan S Commun Psychopharmacol; 1978; 2(6):481-6. PubMed ID: 311720 [No Abstract] [Full Text] [Related]
5. The role of 5-hydroxytryptamine in the behaviour of cats. Shillito EE J Physiol; 1970 Sep; 210(2):162P. PubMed ID: 5313365 [No Abstract] [Full Text] [Related]
6. Metoclopramide antagonism of 5-hydroxytryptophan-induced "wet-dog" shake behaviour in the rat. Fozard JR; Palfreyman MG Naunyn Schmiedebergs Arch Pharmacol; 1979 Jun; 307(2):135-42. PubMed ID: 314597 [No Abstract] [Full Text] [Related]
7. "Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Bedard P; Pycock CJ Neuropharmacology; 1977 Oct; 16(10):663-70. PubMed ID: 304190 [No Abstract] [Full Text] [Related]
8. Serotonin: a possible mediator of behavioral suppression induced by anxiety. Wise CD; Berger BD; Stein L Dis Nerv Syst; 1970 Nov; 31():Suppl:34-7. PubMed ID: 5312689 [No Abstract] [Full Text] [Related]
9. The effect of intracerebroventricularly administered octopamine, phenylethylamine and epinephrine on the central serotonergic system of the rat. Jagiełło-Wójtowicz E Pol J Pharmacol Pharm; 1982; 34(4):193-200. PubMed ID: 6820690 [TBL] [Abstract][Full Text] [Related]
11. [Influence of administration of phenelzine, 5-hydroxytryptophan and their combination, on daily oscillation of the concentration of serotonin in the brain of the albino rat]. Montanaro N; Graziani G Boll Soc Ital Biol Sper; 1967 Jan; 43(1):42-5. PubMed ID: 5298963 [No Abstract] [Full Text] [Related]
12. Subsensitivity to 5-hydroxytryptamine agonists occurs in streptozocin-diabetic rats with no change in [3H]-5-HT receptor binding. Trulson ME; MacKenzie RG J Pharm Pharmacol; 1981 Jul; 33(7):472-4. PubMed ID: 6115040 [No Abstract] [Full Text] [Related]
13. Possible role of brain serotonin and dopamine in controlling male sexual behavior. Gessa GL; Tagliamonte A Adv Biochem Psychopharmacol; 1974; 11(0):217-28. PubMed ID: 4276859 [No Abstract] [Full Text] [Related]
14. [The role of brain 5-hydroxytryptamine in the genesis of stress-induced gastric ulcer in rats]. Yang H; Zhang XJ Sheng Li Xue Bao; 1985 Oct; 37(5):416-24. PubMed ID: 2426787 [No Abstract] [Full Text] [Related]
15. The influence of insulin on 5-methoxytryptamine-induced wet dog shake behavior in rats. Kleinrok Z; Juszkiewicz M Pol J Pharmacol Pharm; 1986; 38(5-6):443-8. PubMed ID: 3554184 [TBL] [Abstract][Full Text] [Related]
16. Evidence that serotonin mediates some behavioral effects of amphetamine. Sloviter RS; Drust EG; Connor JD J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099 [TBL] [Abstract][Full Text] [Related]
17. Development of tolerance to the wet-dog shake behaviour but not the increase in seizure threshold induced by L-5-hydroxytryptophan during continued treatment in rats. Pagliusi SR; Löscher W Psychopharmacology (Berl); 1985; 86(1-2):118-24. PubMed ID: 2410943 [TBL] [Abstract][Full Text] [Related]
18. [Participation of the serotonin-reactive brain structure in certain forms of behavior in golden hamsters]. Popova NK; Bertogaeva VD Farmakol Toksikol; 1975; 38(2):148-51. PubMed ID: 1084283 [TBL] [Abstract][Full Text] [Related]
19. Use of serotonergic agents in the clinical assessment of central serotonin function. Murphy DL; Mueller EA; Garrick NA; Aulakh CS J Clin Psychiatry; 1986 Apr; 47 Suppl():9-15. PubMed ID: 3514586 [TBL] [Abstract][Full Text] [Related]
20. Apomorphine and central serotonin neurons. Grabowska M; Antkiewicz L; Maj J; Michaluk J Pol J Pharmacol Pharm; 1973; 25(1):29-39. PubMed ID: 4272897 [No Abstract] [Full Text] [Related] [Next] [New Search]